|
Save the Date - Expanded Themes Ninth Frye Halloran Symposium Biomarkers and Genetic Alterations in Systemic Cancers and Brain Tumors November 5, 2009 - Ether Dome, Bulfinch Building
November 6, 2009 - Simches Building, 3rd Floor
Massachusetts General Hospital The Frye Halloran Symposia are designed to stimulate rapid changes in the care of patients with brain tumors. Previous symposia have emphasized microdialysis for measurement of therapeutic drugs; radiographic measurements of tumor angiogenesis, primary brain lymphoma, stem cells and glioma, immunization strategies for glioma and racial diversity in glioma patient populations. On November 5-6 , 2009 at the Ninth Frye-Halloran Symposium, a team of international experts will address the issue of novel assays of molecular targets in patients with systemic malignancies and brain tumors.
We invite you to attend this tuition-free meeting.
Speakers will address molecular targets of cancers of lung, breast, and gastrointestinal origin as well as glioblastoma. Emphasis will be placed on common themes such as EGF amplification that appears in lung and brain tumors; the evaluation of chromosomal and protein alterations in tumor patients, and the role of circulating tumor cells. A focus of the meeting will be the discussion of the novel identification of circulating DNA and RNA molecular targets both in glioma and systemic cancers. Clearly the hope is to rapidly advance these technologies by incorporating them into clinical trials of molecularly targeted agents.
The Symposium will be of interest to Medical Oncologists, Clinical Neuro-Oncologists, specialists in studies of 'designer' drugs, scientists working in molecular pathways as well as molecular epidemiologists, clinical trialists and pathologists.
Chairman: Fred H Hochberg, MD
Co-Chairs: Bob S Carter, MD, PhD
Xandra O Breakefield, PhD
Johan Skog, PhD
Administrator: Rita Gould rgould2@partners.org (617)726-8657 |